Unilever PLC (ULVR.L)
London, GB
Unilever Plc engages in the manufacture and sale of consumer goods. It operates through the following segments: Beauty & Wellbeing, Personal Care, Home Care, Nutrition, and Ice Cream. The Beauty & Wellbeing segment offers hair care, skin care, and prestige beauty and health & wellbeing. The Personal Care segment consists of sales of skin cleansing, deodorant, and oral care products. The Home Care segment comprises of sales of fabric care and a wide range of cleaning products. The Nutrition segment refers to sales of scratch cooking aids, dressings, and tea products. The Ice Cream segment covers primarily ice cream products. The company was founded by Antonius Johannes Jurgens, Samuel van den Bergh, and William Hulme Lever in 1930 and is headquartered in London, the United Kingdom.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.36% | -1.50% | -2.13% | -23.07% | -17.73% | -13.46% | -9.58% | +4.38% | -0.81% | +33.68% | +482.30% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 3 | 0 |
| Buy | 5 | -1 |
| Hold | 7 | 0 |
| Sell | 2 | 0 |
| Strong Sell | 0 | -1 |
-
Revenue growth Household & Personal Products: +3.3%-16.9% Q4'25: -30.3% (vs Q4'23)
-
EPS growth Household & Personal Products: +8.8%+19.2% ★ Q4'25: +1.7% (vs Q4'23)
-
FCF margin FCF growth · Household & Personal Products: +44.8%+12.7% Q4'25: +26.9% (vs Q4'23)
-
EBIT margin Household & Personal Products: +9.9%+19.4% ★ Q4'25: +20.6% (vs Q4'23)
-
ROIC Household & Personal Products: +8.2%+16.6% ★ Q4'25: +31.9% (vs Q4'23)
-
Share dilution Household & Personal Products: +0.2%-12.4% ★ Q4'25: -13.2% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Household & Personal Products: -0.51×2.67× Q4'25: 1.59× (vs Q4'23)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2001 actual |
Dec 2002 actual |
Dec 2003 actual |
Dec 2004 actual |
Dec 2005 actual |
Dec 2006 actual |
Dec 2007 actual |
Dec 2008 actual |
Dec 2009 actual |
Dec 2010 actual |
Dec 2011 actual |
Dec 2012 actual |
Dec 2013 actual |
Dec 2014 actual |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 17 Rev. Ana. 13 EPS Ana. |
Dec 2027 17 Rev. Ana. 11 EPS Ana. |
Dec 2028 9 Rev. Ana. 5 EPS Ana. |
Dec 2029 14 Rev. Ana. 4 EPS Ana. |
Dec 2030 8 Rev. Ana. 4 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
52.21B
est: 33.47B (+56.0%)
|
46.53B
est: 31.63B (+47.1%)
|
29.78B
est: 30.96B (-3.8%)
|
38.57B
est: 27.86B (+38.4%)
|
38.40B
est: 27.44B (+39.9%)
|
39.64B
est: 27.46B (+44.3%)
|
40.19B
est: 28.84B (+39.3%)
|
40.52B
est: 33.50B (+21.0%)
|
39.82B
est: 36.41B (+9.4%)
|
44.26B
est: 39.15B (+13.1%)
|
46.47B
est: 41.06B (+13.2%)
|
51.32B
est: 42.17B (+21.7%)
|
49.80B
est: 42.27B (+17.8%)
|
48.44B
est: 39.14B (+23.7%)
|
53.27B
est: 39.02B (+36.5%)
|
52.71B
est: 44.58B (+18.2%)
|
53.72B
est: 47.63B (+12.8%)
|
50.98B
est: 45.84B (+11.2%)
|
51.98B
est: 44.78B (+16.1%)
|
50.72B
est: 45.37B (+11.8%)
|
52.44B
est: 43.54B (+20.5%)
|
60.07B
est: 52.82B (+13.7%)
|
59.60B
est: 70.97B (-16.0%)
|
60.76B
est: 60.64B (+0.2%)
|
50.50B
est: 54.74B (-7.7%)
|
51.19B
50.34B – 51.93B
-6.5% YoY
|
52.55B
51.62B – 53.83B
+2.7% YoY
|
54.27B
53.34B – 55.33B
+3.3% YoY
|
57.94B
56.94B – 59.07B
+6.8% YoY
|
61.16B
60.11B – 62.35B
+5.6% YoY
|
| EBITDA |
8.12B
est: 3.73B (+117.7%)
|
5.61B
est: 3.40B (+64.9%)
|
5.06B
est: 3.36B (+50.4%)
|
6.23B
est: 3.88B (+60.6%)
|
6.48B
est: 4.54B (+42.6%)
|
6.40B
est: 5.34B (+19.8%)
|
6.21B
est: 6.88B (-9.8%)
|
8.64B
est: 6.67B (+29.4%)
|
6.42B
est: 8.36B (-23.2%)
|
7.60B
est: 6.15B (+23.6%)
|
7.81B
est: 6.86B (+13.7%)
|
8.25B
est: 6.82B (+20.9%)
|
8.76B
est: 7.13B (+22.8%)
|
9.56B
est: 7.01B (+36.3%)
|
9.14B
est: 8.54B (+7.1%)
|
9.50B
est: 9.05B (+5.0%)
|
10.26B
est: 8.78B (+16.8%)
|
15.31B
est: 9.25B (+65.5%)
|
11.03B
est: 13.68B (-19.3%)
|
10.72B
est: 9.67B (+10.8%)
|
10.82B
est: 9.98B (+8.4%)
|
13.07B
est: 10.30B (+27.0%)
|
11.99B
est: 14.74B (-18.6%)
|
11.74B
est: 12.66B (-7.3%)
|
11.11B
est: 11.37B (-2.3%)
|
10.63B
10.45B – 10.78B
-6.5% YoY
|
10.91B
10.72B – 11.18B
+2.7% YoY
|
11.27B
11.08B – 11.49B
+3.3% YoY
|
12.03B
11.83B – 12.27B
+6.8% YoY
|
12.70B
12.48B – 12.95B
+5.6% YoY
|
| EBIT |
5.27B
est: 3.97B (+32.9%)
|
7.26B
est: 4.74B (+52.9%)
|
6.71B
est: 5.02B (+33.7%)
|
4.17B
est: 4.95B (-15.9%)
|
5.21B
est: 3.42B (+52.3%)
|
5.42B
est: 5.31B (+2.2%)
|
5.73B
est: 5.68B (+1.0%)
|
7.64B
est: 6.09B (+25.3%)
|
5.39B
est: 7.79B (-30.8%)
|
6.61B
est: 5.40B (+22.5%)
|
6.78B
est: 6.65B (+1.9%)
|
7.05B
est: 6.61B (+6.7%)
|
7.61B
est: 7.01B (+8.6%)
|
8.13B
est: 6.96B (+16.8%)
|
7.77B
est: 8.02B (-3.1%)
|
8.04B
est: 8.43B (-4.7%)
|
8.72B
est: 8.22B (+6.1%)
|
13.09B
est: 8.16B (+60.5%)
|
9.05B
est: 12.75B (-29.0%)
|
8.70B
est: 8.95B (-2.8%)
|
9.05B
est: 9.24B (-2.0%)
|
11.13B
est: 9.53B (+16.7%)
|
10.41B
est: 12.63B (-17.6%)
|
9.99B
est: 10.43B (-4.2%)
|
9.79B
est: 9.75B (+0.5%)
|
9.11B
8.96B – 9.24B
-6.5% YoY
|
9.35B
9.19B – 9.58B
+2.7% YoY
|
9.66B
9.50B – 9.85B
+3.3% YoY
|
10.31B
10.14B – 10.52B
+6.8% YoY
|
10.89B
10.70B – 11.10B
+5.6% YoY
|
| Net Income |
1.84B
est: 507.60M (+262.1%)
|
2.06B
est: 921.25M (+123.4%)
|
1.85B
est: 438.54M (+321.4%)
|
2.76B
est: 704.01M (+291.3%)
|
3.77B
est: 586.46M (+542.2%)
|
4.75B
est: 3.76B (+26.2%)
|
3.89B
est: 4.98B (-22.0%)
|
5.03B
est: 4.52B (+11.3%)
|
3.37B
est: 5.46B (-38.3%)
|
4.24B
est: 3.62B (+17.1%)
|
4.25B
est: 4.45B (-4.5%)
|
4.48B
est: 4.37B (+2.6%)
|
4.84B
est: 4.49B (+7.8%)
|
5.17B
est: 4.48B (+15.3%)
|
4.91B
est: 5.20B (-5.5%)
|
5.18B
est: 5.51B (-5.9%)
|
6.05B
est: 5.46B (+10.8%)
|
9.39B
est: 5.83B (+61.2%)
|
5.63B
est: 9.34B (-39.8%)
|
5.58B
est: 5.76B (-3.1%)
|
6.05B
est: 5.94B (+1.8%)
|
7.64B
est: 8.29B (-7.8%)
|
6.49B
est: 6.86B (-5.5%)
|
5.74B
est: 6.88B (-16.6%)
|
5.99B
est: 6.67B (-10.2%)
|
6.86B
6.58B – 7.15B
+3.0% YoY
|
7.30B
7.05B – 7.55B
+6.4% YoY
|
7.82B
7.64B – 8.02B
+7.1% YoY
|
8.23B
8.05B – 8.44B
+5.3% YoY
|
8.97B
8.77B – 9.20B
+9.0% YoY
|
| SGA |
—
est: 22.50B (-100.0%)
|
19.22B
est: 16.23B (+18.4%)
|
15.99B
est: 17.58B (-9.0%)
|
15.65B
est: 13.33B (+17.4%)
|
9.08B
est: 15.49B (-41.4%)
|
14.14B
est: 6.52B (+116.8%)
|
14.38B
est: 14.43B (-0.3%)
|
12.01B
est: 15.88B (-24.4%)
|
9.47B
est: 13.25B (-28.5%)
|
11.73B
est: 13.22B (-11.3%)
|
12.10B
est: 14.14B (-14.4%)
|
13.63B
est: 12.43B (+9.6%)
|
13.04B
est: 13.66B (-4.6%)
|
11.21B
est: 14.98B (-25.2%)
|
14.07B
est: 14.26B (-1.4%)
|
13.80B
est: 19.41B (-28.9%)
|
12.93B
est: 17.86B (-27.6%)
|
11.94B
est: 16.03B (-25.5%)
|
12.12B
est: 11.88B (+2.0%)
|
11.87B
est: 12.38B (-4.1%)
|
11.70B
est: 12.77B (-8.4%)
|
14.44B
est: 13.18B (+9.6%)
|
14.30B
est: 17.06B (-16.2%)
|
15.20B
est: 14.66B (+3.7%)
|
12.56B
est: 13.16B (-4.6%)
|
12.31B
12.10B – 12.49B
-6.5% YoY
|
12.63B
12.41B – 12.94B
+2.7% YoY
|
13.05B
12.83B – 13.30B
+3.3% YoY
|
13.93B
13.69B – 14.20B
+6.8% YoY
|
14.71B
14.45B – 14.99B
+5.6% YoY
|
| EPS |
0.60
est: 0.62 (-2.5%)
|
0.69
est: 0.50 (+38.0%)
|
94.07
est: 0.63 (+14,909.4%)
|
94.36
est: 0.57 (+16,428.0%)
|
1.30
est: 0.87 (+49.8%)
|
1.65
est: 0.87 (+90.6%)
|
1.35
est: 1.01 (+34.0%)
|
1.79
est: 1.19 (+50.3%)
|
1.21
est: 1.15 (+4.9%)
|
1.51
est: 1.26 (+20.1%)
|
1.51
est: 1.32 (+14.3%)
|
1.58
est: 1.29 (+22.0%)
|
1.71
est: 1.29 (+32.1%)
|
1.82
est: 1.29 (+40.9%)
|
1.73
est: 1.33 (+29.7%)
|
1.83
est: 1.68 (+8.8%)
|
2.16
est: 2.09 (+3.3%)
|
3.50
est: 2.20 (+58.7%)
|
2.15
est: 2.31 (-6.9%)
|
2.13
est: 2.37 (-10.1%)
|
2.33
est: 2.26 (+3.3%)
|
2.92
est: 2.43 (+20.0%)
|
2.56
est: 3.12 (-18.0%)
|
2.30
est: 3.13 (-26.5%)
|
2.74
est: 3.04 (-9.8%)
|
3.17
3.00 – 3.26
+4.2% YoY
|
3.33
3.21 – 3.44
+5.2% YoY
|
3.56
3.48 – 3.65
+6.9% YoY
|
3.75
3.67 – 3.85
+5.3% YoY
|
4.09
4.00 – 4.19
+9.0% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B | 3/5 | 3/5 | 5/5 | 4/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-28 | B | 3/5 | 3/5 | 5/5 | 4/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-27 | B | 3/5 | 3/5 | 5/5 | 4/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-26 | B | 3/5 | 3/5 | 5/5 | 4/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-22 | B | 3/5 | 3/5 | 5/5 | 4/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-21 | B | 3/5 | 3/5 | 5/5 | 4/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-20 | B | 3/5 | 3/5 | 5/5 | 4/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-19 | B | 3/5 | 3/5 | 5/5 | 4/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-18 | B | 3/5 | 3/5 | 5/5 | 4/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-15 | B | 3/5 | 3/5 | 5/5 | 4/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-14 | B | 3/5 | 3/5 | 5/5 | 4/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-13 | B | 3/5 | 3/5 | 5/5 | 4/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-12 | B | 3/5 | 3/5 | 5/5 | 4/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-11 | B | 3/5 | 3/5 | 5/5 | 4/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-08 | B | 3/5 | 4/5 | 5/5 | 4/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-07 | B | 3/5 | 4/5 | 5/5 | 4/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-06 | B | 3/5 | 3/5 | 5/5 | 4/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-05 | B | 3/5 | 3/5 | 5/5 | 4/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-01 | B | 3/5 | 3/5 | 5/5 | 4/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-30 | B | 3/5 | 3/5 | 5/5 | 4/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-29 | B | 3/5 | 4/5 | 5/5 | 4/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-28 | B | 3/5 | 4/5 | 5/5 | 4/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-27 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-24 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-23 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-22 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-21 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-20 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-17 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-16 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-15 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Fernando Fernandez | Chief Executive Officer & Director | 3M | male |
| Hein A. Schumacher | Executive Officer | 2M | male |
| Srinivas Phatak | Chief Financial Officer & Director | 1M | male |
| Mairead Nayager | Chief People Officer | — | female |
| Michael Stewart | Chief Corporate Affairs & Communications Officer | — | male |
| Prakash Kakkad | Chief Legal Officer & Group Company Secretary | — | male |
| Reema Jain | Chief Information Officer | — | female |
| Wilhelmus Uijen | Chief Supply Chain & Operations Officer | — | male |
| Jemma Spalton | Head of Investor Relations | — | female |
| Leandro Barreto | Chief Marketing Officer and Chief Marketing Officer of Beauty & Wellbeing | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for ULVR.L
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
